Drugs / sodium chloride
last change 3 days ago re-read 2 minutes ago

sodium chloride

Developed for
acute bronchiolitis · acute kidney injury · infectious disease with sepsis · cystic fibrosis · atopic eczema · brain edema · bronchiolitis · chronic rhinosinusitis
+59 more · COVID-19 · impaired renal function disease · postural orthostatic tachycardia syndrome · acute hypotension · acute myocardial infarction · bipolar disorder · brain injury · bronchiectasis · cardiac arrest · chronic kidney disease · chronic pain syndrome · congestive heart failure · constipation disorder · corneal edema · decubitus ulcer · dehydration polycythemia · diabetic ketoacidosis · disorder of acid-base balance · dry eye syndrome · heart failure · hypertensive disorder · hypotensive disorder · ischemic stroke · keratitis · lipoma · migraine disorder · myalgic encephalomeyelitis/chronic fatigue syndrome · neurally mediated hypotension · neurogenic bowel · osteoarthritis, knee · periapical periodontitis · psoriasis · pulpitis · sinusitis · Sjogren syndrome · skin atrophy · traumatic brain injury · acute pancreatitis · acute tubulointerstitial nephritis · brain infarction · chemotherapy-induced oral mucositis · cirrhosis of liver · disease related to solid organ transplantation · end stage renal failure · epicondylitis · gastroenteritis · hemorrhagic stroke · metabolic acidosis · neonatal respiratory failure · premenstrual tension · pulmonary edema · respiratory tract infectious disorder · skin infection · ST-elevation myocardial infarction · stroke disorder · subarachnoid hemorrhage · urinary tract infection · urinary tract obstruction · vascular occlusion disorder
Investigated by
Assistance Publique - Hôpitaux de Paris · Assiut University · Bayside Health · Canadian Institutes of Health Research (CIHR) · Capital Medical University · Chang Gung Memorial Hospital
+127 more · Children's Hospital Los Angeles · Cystic Fibrosis Foundation · Glostrup University Hospital, Copenhagen · Johns Hopkins University · NYU Langone Health · National Heart, Lung, and Blood Institute (NHLBI) · Ospedale Misericordia e Dolce · Seoul National University Hospital · University of Alberta · University of California, San Francisco · University of Monastir · University of North Carolina, Chapel Hill · AXIOM Real Time Metrics · Aalborg University Hospital · Adhish Agarwal · Alfasigma S.p.A. · All India Institute of Medical Sciences, Bhubaneswar · Analytica Ventures LLC · Baxter Healthcare Corporation · Beijing Anzhen Hospital · Bispebjerg Hospital · CMH Multan Institute of Medical Sciences · Can Tho University of Medicine and Pharmacy · Canadian Blood Services · Children's & Women's Health Centre of British Columbia · Christiana Care Health Services · Cook County Health · Cystic Fibrosis Federation Australia · Dan Leibovici · David Garcia Cinca · Derk Jan Jager · Dinara Zhumanbayeva · Dongyang People's Hospital · Dr. Damon Scales · Eli Lilly and Company · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Euraxi Pharma · Eye-yon Medical · Fayoum University Hospital · Federal Teaching Hospital Abakaliki · Fondo de Investigacion Sanitaria · Fundacion Clinic per a la Recerca Biomédica · Fundacion Clinica Valle del Lili · Hala Abd EL-Tawab Ibrahim Radwan · Hamad Medical Corporation · Hamilton Health Sciences Corporation · Herlev Hospital · Hillerod Hospital, Denmark · Holbaek Sygehus · Hospital Universitario Ramon y Cajal · Hospital do Coracao · IRCCS Burlo Garofolo · Innovative Medical · Islamabad Medical and Dental College · Jeffrey Alan Klein, MD · Jinhua Municipal Central Hospital · Jinhua People's Hospital · Jinnah Postgraduate Medical Centre · KU Leuven · Kentucky Spinal Cord and Head Injury Research Board · LEO Foundation · Lanxi People's Hospital · Linkoeping University · Mardan Medical Complex · Mayo Clinic · Medical University of South Carolina · Milton S. Hershey Medical Center · Monash University · Montefiore Medical Center · National Health and Medical Research Council, Australia · National Institute of Neurological Disorders and Stroke (NINDS) · National Institute on Aging (NIA) · National Institutes of Health (NIH) · Nemours Children's Clinic · all 133 on the full record

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) THAM 1965-12-16 fda.gov

Trials 100 · started per year

today
US approved 1965
2
1
1
1
2
3
3
4
3
3
4
3
9
4
7
5
2
4
7
6
4
5
4
5
7
19651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 05 trials
Phase 0 NCT05634213 Mar 2023 → Apr 2025 cardiac valvular defect Ottawa Heart Institute Research Corporation Withdrawn No outcome recorded
Phase 0 NCT06139029 Nov 2022 → Mar 2023 acute bronchiolitis Mardan Medical Complex Completed No outcome recorded
Phase 0 NCT05029596 Feb 2020 → Mar 2023 cancer University of Texas Southwestern Medical Center Completed No outcome recorded
Phase 0 NCT03837470 May 2019 → Feb 2020 diastolic heart failure Adhish Agarwal Completed No outcome recorded
Phase 0 NCT04197245 Jan → Jul 2019 skin atrophy Jinnah Postgraduate Medical Centre Completed No outcome recorded
Phase 15 trials
Phase 1 NCT05154968 Nov → Dec 2021 Eli Lilly and Company Completed No outcome recorded
Phase 1 NCT04147182 Dec 2018 → Jul 2019 Dan Leibovici Unknown No outcome recorded
Phase 1 NCT02947126 Jan 2017 → Feb 2020 cystic fibrosis Tim Corcoran Completed No outcome recorded
Phase 1 NCT02854683 Feb 2016 → Dec 2021 myalgic encephalomeyelitis/chronic fatigue syndrome, neurally mediated hypotension, postural orthostatic tachycardia syndrome New York Medical College Unknown No outcome recorded
Phase 1 NCT01094704 Nov 2009 → May 2010 cystic fibrosis University of North Carolina, Chapel Hill Completed No outcome recorded
Phase 1/24 trials
Phase 1/2 NCT06820164 May 2025 → Jan 2027 expected lipoma West Virginia University Recruiting No outcome recorded
Phase 1/2 NCT06370975 Aug 2024 → Aug 2025 Assiut University Unknown No outcome recorded
Phase 1/2 NCT01073787 Jul 2010 → Nov 2012 migraine disorder University of Alberta Completed No outcome recorded
Phase 1/2 NCT00228657 Jul 2002 → Aug 2003 decubitus ulcer Bayside Health Completed No outcome recorded
Phase 28 trials
Phase 2 NCT06471998 Feb 2025 → Mar 2026 chronic pain syndrome Ramsay Santé Completed No outcome recorded
Phase 2 NCT04344236 Apr → May 2020 COVID-19 NYU Langone Health Withdrawn No outcome recorded
Phase 2 NCT04785755 Nov 2017 → Mar 2020 Hala Abd EL-Tawab Ibrahim Radwan Completed No outcome recorded
Phase 2 NCT01042015 Oct 2016 → Nov 2025 cardiac arrest University of Maryland, Baltimore Terminated No outcome recorded
Phase 2 NCT02142985 Apr 2014 → Apr 2015 University of Monastir Completed No outcome recorded
Phase 2 NCT01411852 Mar 2012 → Apr 2013 brain injury University of Washington Completed No outcome recorded
Phase 2 NCT00819416 Feb → Oct 2009 infectious disease with sepsis Ottawa Hospital Research Institute Completed No outcome recorded
Phase 2 NCT01293084 Jul 2007 → Jun 2009 cystic fibrosis Johns Hopkins University Completed No outcome recorded
Phase 2/36 trials
Phase 2/3 NCT06558461 Jun 2022 → May 2024 acute bronchiolitis Can Tho University of Medicine and Pharmacy Completed No outcome recorded
Phase 2/3 NCT04802408 Oct 2021 → May 2026 overdue COVID-19 Milton S. Hershey Medical Center Active not recruiting No outcome recorded
Phase 2/3 NCT04802785 Jun → Jul 2021 Dinara Zhumanbayeva Unknown No outcome recorded
Phase 2/3 NCT04242368 Jul 2020 → Jul 2021 chronic rhinosinusitis Stanford University Withdrawn No outcome recorded
Phase 2/3 NCT00619918 Feb 2008 → May 2011 bronchiolitis Children's Hospital Los Angeles Completed No outcome recorded
Phase 2/3 NCT00163852 Feb 2004 → Feb 2006 cystic fibrosis Bayside Health Unknown No outcome recorded
Phase 313 trials
Phase 3 NCT07596329 Sep 2026 → Nov 2027 expected chronic kidney disease, congestive heart failure University of Monastir Not yet recruiting No outcome recorded
Phase 3 NCT06953674 Jun 2025 → Jun 2029 expected traumatic brain injury University of Louisville Recruiting No outcome recorded
Phase 3 NCT05962255 Feb 2022 → Apr 2024 heart failure Wroclaw Medical University Completed No outcome recorded
Phase 3 NCT05121389 Jan 2021 → Nov 2022 ischemic stroke Chang Gung Memorial Hospital Unknown No outcome recorded
Phase 3 NCT02872155 Jul 2017 → Jul 2019 impaired renal function disease David Garcia Cinca Completed No outcome recorded
Phase 3 NCT02875873 May 2017 → Mar 2020 acute kidney injury Hospital do Coracao Completed No outcome recorded
Phase 3 NCT02905760 Dec 2016 → Nov 2018 acute myocardial infarction Assistance Publique - Hôpitaux de Paris Unknown No outcome recorded
Phase 3 NCT03106922 Apr 2016 → Jul 2020 Alfasigma S.p.A. Unknown No outcome recorded
Phase 3 NCT01786824 Dec 2014 → Aug 2015 acute kidney injury, impaired renal function disease Nîmes University Hospital Terminated No outcome recorded
Phase 3 NCT02221024 Jul 2011 → Sep 2013 IRCCS Burlo Garofolo Completed No outcome recorded
Phase 424 trials
Phase 4 NCT07487831 Jun 2026 → Mar 2028 expected atopic eczema, psoriasis University of California, San Francisco Not yet recruiting No outcome recorded
Phase 4 NCT07447063 Jun 2026 → Mar 2028 expected atopic eczema University of California, San Francisco Not yet recruiting No outcome recorded
Phase 4 NCT06242795 Oct 2024 → Jun 2026 overdue bronchiectasis University of North Carolina, Chapel Hill Recruiting No outcome recorded
Phase 4 NCT06441162 Jul 2024 → May 2025 acute bronchiolitis NYU Langone Health Terminated No outcome recorded
Phase 4 NCT07108881 May → Dec 2024 acute hypotension University Tunis El Manar Completed No outcome recorded
Phase 4 NCT06076590 Nov 2021 → May 2023 acquired aneurysmal subarachnoid hemorrhage Capital Medical University Completed No outcome recorded
Phase 4 NCT05109000 Nov 2021 → Jan 2022 Jeffrey Alan Klein, MD Unknown No outcome recorded
Phase 4 NCT03880903 Jul 2020 → Mar 2021 acute bronchiolitis Assiut University Unknown No outcome recorded
Phase 4 NCT03068741 Mar 2020 → Nov 2025 infectious disease with sepsis Dr. Damon Scales Completed No outcome recorded
Phase 4 NCT04222816 Jan 2020 → Dec 2021 bipolar disorder All India Institute of Medical Sciences, Bhubaneswar Completed No outcome recorded
Phase not applicable35 trials
NCT07598188 Jul 2026 → Jan 2027 expected periapical periodontitis Islamabad Medical and Dental College Not yet recruiting No outcome recorded
NCT07490808 Mar → Jul 2026 overdue acute kidney injury, atrial fibrillation Beijing Anzhen Hospital Recruiting No outcome recorded
NCT07267897 Mar → Jun 2026 overdue Sakarya University Not yet recruiting No outcome recorded
NCT07452588 Feb → Aug 2026 overdue keratitis Sohag University Not yet recruiting No outcome recorded
NCT07260240 Dec 2025 → Mar 2026 Queen Savang Vadhana Memorial Hospital, Thailand Completed No outcome recorded
NCT07486245 Mar → Nov 2025 pulpitis CMH Multan Institute of Medical Sciences Completed No outcome recorded
NCT06022302 Oct 2023 → Nov 2024 metabolic disease University of Copenhagen Completed No outcome recorded
NCT06343493 Jun → Dec 2023 chronic rhinosinusitis Rawalpindi Medical College Completed No outcome recorded
NCT05921695 May 2023 → Jun 2026 Second Affiliated Hospital, School of Medicine, Zhejiang University Terminated No outcome recorded
NCT05707936 Feb → Sep 2023 Chang Gung Memorial Hospital Unknown No outcome recorded
Also used as a comparator or background therapy in 178 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 04 trials
Phase 0 NCT05505708 Comparator Dec 2022 → Jan 2023 pulmonary edema Kasr El Aini Hospital Unknown No outcome recorded
Phase 0 NCT03330704 Comparator Nov 2017 → Jan 2020 brain edema Stanford University Withdrawn No outcome recorded
Phase 0 NCT03246282 Background Feb 2017 → Dec 2018 John W. Reeves, MD Suspended No outcome recorded
Phase 0 NCT02989571 Comparator Mar 2016 → Dec 2020 MemorialCare Health System Completed No outcome recorded
Phase 16 trials
Phase 1 NCT03340805 Comparator Jan → Aug 2018 Children's Hospital of Philadelphia Completed No outcome recorded
Phase 1 NCT03306589 Background Aug 2017 → Jan 2018 rheumatoid arthritis GlaxoSmithKline Completed No outcome recorded
Phase 1 NCT03204955 Comparator Jun 2017 → Sep 2018 acute kidney injury, subarachnoid hemorrhage Emory University Completed No outcome recorded
Phase 1 NCT03063476 Background Mar → May 2017 Vanderbilt University Medical Center Completed No outcome recorded
Phase 1 NCT03391414 Comparator Aug 2014 → Jul 2016 cystic fibrosis Joseph Pilewski Completed No outcome recorded
Phase 1/24 trials
Phase 1/2 NCT04206943 Background Oct 2019 → Jan 2021 acute lymphoblastic leukemia Acibadem University Unknown No outcome recorded
Phase 1/2 NCT02227329 Background Jul 2014 → Oct 2016 Mayo Clinic Terminated No outcome recorded
Phase 1/2 NCT01087853 Comparator Mar 2010 → Mar 2011 disorder of acid-base balance, water intoxication University of Nottingham Completed No outcome recorded
Phase 1/2 NCT01547130 Comparator May 2008 → Dec 2010 colonic neoplasm Arya, Vijaypal, M.D., P.C. Completed No outcome recorded
Phase 224 trials
Phase 2 NCT05909150 Comparator Nov 2023 → Mar 2027 expected acute kidney injury Fernando Bacal Recruiting No outcome recorded
Phase 2 NCT05196581 Comparator Dec 2021 → Jul 2022 COVID-19 Suzana Erico Tanni Minamoto Completed No outcome recorded
Phase 2 NCT04842721 Comparator Jul → Oct 2021 COVID-19 Rafik Batroussy Withdrawn No outcome recorded
Phase 2 NCT03166228 Comparator Jan 2018 → Jun 2022 hypertensive disorder Assiut University Completed No outcome recorded
Phase 2 NCT02985060 Background Nov 2016 → Nov 2017 ischemic stroke Seoul National University Hospital Unknown No outcome recorded
Phase 2/38 trials
Phase 2/3 NCT05869565 Comparator Feb 2023 → Feb 2024 stroke disorder Aga Khan University Unknown No outcome recorded
Phase 2/3 NCT02950883 Comparator Mar 2015 → Dec 2020 cystic fibrosis University of Washington, the Collaborative Health Studies Coordinating Center Completed No outcome recorded
Phase 2/3 NCT02752308 Comparator Sep 2014 → Mar 2015 hypospadias Isfahan University of Medical Sciences Completed No outcome recorded
Phase 2/3 NCT02088502 Comparator Sep 2013 → Apr 2014 Isfahan University of Medical Sciences Unknown No outcome recorded
Phase 2/3 NCT02114346 Background Jul 2013 → Feb 2014 Isfahan University of Medical Sciences Completed No outcome recorded
Phase 334 trials
Phase 3 NCT07497542 Comparator Apr 2026 → Aug 2029 expected brain infarction Tianjin Medical University General Hospital Not yet recruiting No outcome recorded
Phase 3 NCT06020495 Background Dec 2024 → Sep 2026 expected Assistance Publique - Hôpitaux de Paris Recruiting No outcome recorded
Phase 3 NCT06030609 Comparator Sep 2024 → Feb 2026 disorder of acid-base balance King Chulalongkorn Memorial Hospital Completed No outcome recorded
Phase 3 NCT06545565 Comparator Jul 2024 → May 2025 overdue metabolic acidosis Aga Khan University Hospital, Pakistan Recruiting No outcome recorded
Phase 3 NCT06363877 Comparator Jun 2024 → Oct 2026 expected Loma Linda University Recruiting No outcome recorded
Phase 443 trials
Phase 4 NCT07437339 Comparator Mar 2026 → Dec 2027 expected Inova Health Care Services Recruiting No outcome recorded
Phase 4 NCT06541535 Comparator Nov 2025 → Dec 2027 expected diabetic ketoacidosis Centre Hospitalier Universitaire de Nice Recruiting No outcome recorded
Phase 4 NCT07035509 Comparator Jul 2025 → Jul 2026 overdue infectious disease with sepsis Fundación Cardioinfantil Instituto de Cardiología Not yet recruiting No outcome recorded
Phase 4 NCT07286526 Comparator Aug 2024 → Mar 2025 acute kidney injury Yunus Emre Gemici Completed No outcome recorded
Phase 4 NCT06374823 Comparator May 2024 → Dec 2026 expected critical illness polyneuropathy, hemorrhagic stroke Capital Medical University Not yet recruiting No outcome recorded
Phase not applicable55 trials
NCT07550790 Comparator Jul 2026 → Jun 2027 expected heart failure, impaired renal function disease Jin Joo Park Recruiting No outcome recorded
NCT07385560 Background Feb → May 2026 overdue osteoarthritis, knee, popliteal cyst Istanbul University - Cerrahpasa Not yet recruiting No outcome recorded
NCT07202559 Comparator Oct 2025 → Dec 2027 expected acute pancreatitis, chronic pancreatitis Changhai Hospital Recruiting No outcome recorded
NCT07188766 Comparator Oct 2025 → Aug 2028 expected vascular occlusion disorder Imam Abdulrahman Bin Faisal University Recruiting No outcome recorded
NCT07647575 Comparator Oct 2025 → Apr 2028 expected bronchiectasis, pulmonary non-tuberculous mycobacterial infection Taipei Veterans General Hospital, Taiwan Recruiting No outcome recorded

Evidence & citations 37 cited values

Every value below carries the sentence it was read from. 282 sources stand behind the page.

FieldValueCited text
Known as sodium chloride “Following aspiration, an injection mixture consisting of 1 mL betamethasone, 1 mL of 2% lidocaine, and 1 mL of 0.9% isotonic sodium chloride is administered into the...” NCT07385560
121

“The aim of this study is to determine whether sodium bicarbonate is superior to sodium chloride in preventing contrast induced nephropathy in diabetic patients undergoing...” NCT00950079

“Treatment of the metabolic alkalosis with volume and sodium chloride (NaCl) replacement could reduce hypoventilation and hypercapnia, thereby improving symptoms, sleep patterns...” NCT00163852

“3% and 5% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, hypertonic solution for fluid and electrolyte replenishment in single dose containers for intravenous...” NCT04147182

“The Active Rinse is a 25 ml of Hypertonic Saturated Saline solution made by mixing 10 grams of Sodium Chloride (Table Salt) in 25 ml of Tap water with some salt crystals deposited.” NCT04842721

“0.9 percent sodium chloride will be administered via IV route to all subjects at a rate of 250 mL/hour for 4 hours prior to dosing with LPS and 8 hours after dosing with LPS.” NCT03306589

“Patients received 4 mL of 3% sodium chloride (hypertonic saline [HS group]) or 0.9% sodium chloride (normal saline [NS group]) inhaled as many as 3 times in the ED.” PMID 24862623 Jul 2014

“Patients were randomized to receive intravenous volume supplementation with either (A) sodium chloride 0.9% 1 mL/kg/h for at least 12h prior and after the procedure” PMID 22267245 Jan 2012

“0.9 % sodium chloride (NaCl) intravenous (IV) fluid replacement in children with moderate to severe dehydration secondary to acute gastroenteritis (AGE).” PMID 27480410 Aug 2016

“randomized to receive a 154-mEq/L infusion of either sodium chloride (n = 59) or sodium bicarbonate (n = 60) before and after iopamidol administration” PMID 15150204 May 2004

“The coload group received a sodium chloride 0.9% perfusion as rapidly as possible starting at the time of intrathecal injection for spinal anesthesia.” NCT03107598

“Standard treatment for rotavirus which includes rehydration therapy and antipyretic therapy including sodium chloride fluid and paracetamol infusion” NCT07167797

“Most nasal irrigations use normal saline (0.9% sodium chloride), which approximates the physiological concentration of plasma in the blood.” NCT02413125

“prime solution containing Ringer-Acetate 1000 ml + Mannitol 400 ml (60 g) + Sodium-Chloride 40 ml (160 mmol) and Heparin 2 ml (10 000 IU)” NCT05914896

“prepared from sodium chloride 0.9% intravenous solution and sodium chloride 3% intravenous solution (, Egypt Otsuka Pharmaceutical Co.).” NCT04785755

“Lidocaine-saline group were injected with 2 ml of lidocaine hydrochloride (20 mg/ml) and 6 ml of a 0.9% sodium chloride mixture.” NCT07503574

“large quantity of ice-cold saline (0.9% Sodium Chloride for Injection USP) will be pumped as rapidly as possible into the aorta” NCT01042015

“Sachet B: sodium citrate 1.863 g, anhydrous citric acid 0.813 g, sodium chloride 0.730 g, potassium chloride 0.370 g;” NCT03106922

“Patients were randomised to receive standard SC with nebulisation of 4 mL of 3% sodium chloride every 6 hours” PMID 31488402 Sep 2019

“NSCLS contained 0.9% sodium chloride at a pH 4.5-7.0, and was used to lock NSCLS-group patient catheters.” NCT03627884

“4 mL mepivacaine chlorhydrate 20 mg/mL with epinephrine 5 mcg/mL diluted with 16 mL sodium chloride 0.9%” NCT01611324

“Tranexamic Acid would be diluted in 0,9% Sodium Chloride (0,9% NaCl) to cumulative volume of 20 ml.” NCT03070847

“supplemental 3ml 0.9% Sodium chloride (NaCl) solution in a nasal nebuliser once a day for 3 months” NCT03011632

“0.9% sodium chloride at 1 ml/kg/h is administered via a slow intravenous perfusion.” NCT01786824

“Isotonic Saline (0.9% sodium chloride) 1 mL/kg/h for 12 hours after the procedure” NCT00770614

“normal salt' condition (2300 mg sodium chloride pills + 1200 mg dietary sodium)” NCT01566084

“300mg sodium chloride consumed in a capsule on two occasions with 300ml water” NCT03948230

“HUK (0.15 PNA) and sodium chloride injection (100ml), once per day” NCT06848894

Sodium Chloride 3% solution, previously prepared in 5 mL syringes.” NCT02045238

“Intravenous fluid resuscitation with saline (0.9% sodium chloride)” NCT00935168

“saline injection contains 0.9% isotonic sodium chloride solution” NCT04197245

“Both arms were treated with 5% sodium chloride 6 times a day.” PMID 33014443 Sep 2020

“effectiveness of inhaled sodium chloride therapy (BREATHOX®)” NCT05196581

“0.9% sodium chloride solution 2000 ml / day i.v. infusion” NCT04206943

“Catheters will be sealed with 3mL of 0.9% sodium chlorideNCT05209841

“154mEq/L of sodium chloride is given intravenously.” NCT01210456

“0.9% sodium chloride solution, Glycerol, Glycerin” NCT02435069

“PARI Hyper-Sal™ Sodium Chloride Solution - 7%” NCT02276898

“Fluid expansion, Sodium Chloride NaCl 0.9%.” NCT02905760

“250 ml of 0.9% Sodium Chloride Solution” NCT03246282

“150 ml of 0.9% Sodium Chloride Solution” NCT02785133

“0.9% Sodium chloride intravenous fluid” NCT01449721

Sodium Chloride (NaCl) 2.6 g. per os” NCT04802785

sodium chloride 3% 150ml for 20 min” NCT06020495

“0.45% Sodium Chloride/5% dextrose” NCT00632775

“intravenous 0.9% sodium chloridePMID 29130810 Nov 2017

“saline (0.9% sodium chloride)” NCT06076590

sodium chloride 0,9%” NCT01636089

“7% sodium chlorideNCT06242795

sodium ChlorideNCT06545565

NCT02462902

NCT01782573

NCT07267897

NCT02046135

NCT01094704

NCT02835157

NCT06114459

NCT05109000

NCT06545565

NCT02421419

NCT00353340

NCT07487831

NCT00575484

NCT00700375

NCT05808972

NCT06441162

NCT06820164

NCT00384995

NCT06471998

NCT00228657

NCT00706771

NCT01066624

NCT02172092

NCT02142985

NCT07452588

NCT03204955

NCT02721654

NCT00639912

NCT02622126

NCT02668952

NCT00995683

NCT05154968

NCT05909150

NCT01488448

NCT06558461

NCT02542241

NCT05869565

NCT03829488

NCT00522756

NCT04215042

NCT02405377

NCT04680936

NCT02686151

NCT01411852

NCT05962255

NCT00608790

NCT02561325

NCT01654328

NCT07490808

NCT00493662

NCT02718521

NCT07596329

NCT07447063

NCT02225431

NCT03837470

NCT04213508

NCT02752308

NCT02037815

NCT03961048

NCT02067195

NCT07188766

NCT03476460

NCT03391414

NCT04222816

NCT03371199

NCT03954860

NCT02822131

NCT03529097

NCT01795638

NCT03330704

NCT03048162

NCT02707549

Known as 0.9 % Normal Saline “A 20 mL/kg 0.9% normal saline bolus (maximum 999 mL) will be administered over 1 hour.” NCT00392145
1

NCT07550790

Known as 0.9% NaCl “After postoperative admission to the intensive care unit (ICU), patients will be randomly assigned to receive 5 ml/kg ideal body weight HS (7.3% NaCl) or normal saline (NS,...” PMID 31200756 Jun 2019
6

“Normal saline (0.9% NaCl) is an isotonic solution that is widely used for intravenous application but is also used as our SOC for wound irrigation.” NCT01939145

“Sodium chloride (0.9%) referred as 0.9% NaCl for 72 hours post symptom onset (60-72 hourspost randomization)” NCT05869565

“Tranexamic Acid would be diluted in 0,9% Sodium Chloride (0,9% NaCl) to cumulative volume of 20 ml.” NCT03070847

“Normal Saline (0.9% NaCl)” NCT06953674

NCT01573117

NCT00734214

Known as 0.9% saline “In Phase A, 12 subjects will receive 2 litres of 0.9% saline BP (Baxter Health Care, Thetford, UK) or Plasmalyte® (Baxter Health Care, Thetford, UK).” NCT01087853
7

“A total of 1500 ml 0.9% saline hydration therapy was administered over 2.5 hours.” NCT07286526

“Drug : ringer lactate, 0.9% saline, VOLUVEN ®” NCT01972828

NCT03420261

NCT02528448

NCT01365793

NCT04512950

NCT03685214

Known as 0.9% sodium chloride “Participants assigned to the hydration group will receive 0.9% sodium chloride intravenously at 2 mL/kg/h starting when the participant enters the electrophysiology laboratory...” NCT07490808
7

“saline (0.9% sodium chloride)” PMID 28651514 Jun 2017

NCT07437339

NCT02088502

NCT04043598

NCT02114346

NCT02233985

NCT05752279

Known as 0.9% Sodium Chloride for Injection USP “large quantity of ice-cold saline (0.9% Sodium Chloride for Injection USP) will be pumped as rapidly as possible into the aorta” NCT01042015
Known as 0.9% Sodium Chloride Saline “Isotonic Saline ( 0.9% Sodium Chloride Saline)” NCT04213508
Known as 0.9% sodium chloride solution “normal saline (0.9% sodium chloride solution)” NCT02590081
Known as 3% Sodium Chloride Saline “Hypertonic Saline ( 3% Sodium Chloride Saline)” NCT04213508
Known as bacteriostatic saline ClinicalTrials.gov intervention name — accepted as the source's own label NCT02209272
Known as hypersel “Hypertonic saline at the concentration of 3% (hypersel) has been injected for years into echinococcal cysts to kill live scolices” NCT04147182
Known as Hypertonic Saline “Patients will receive inhaled Hypertonic Saline 3%, initially with a 2 hour interval, and clinical evaluation prior to each inhalation.” NCT02045238
1

Hypertonic Saline ( 3% Sodium Chloride Saline)” NCT04213508

Known as isotonic saline Isotonic saline (NaCl 0.9%), called "physiological serum" is the standard fluid for the resuscitation of severely injured patients.” NCT03630224
17

Isotonic Saline ( 0.9% Sodium Chloride Saline)” NCT04213508

NCT00953940

NCT05953675

NCT06541535

NCT02950883

NCT00709280

NCT01223183

NCT01742130

NCT01619657

NCT02947126

NCT00770614

NCT00606827

NCT02980003

NCT04242368

NCT01952470

NCT02378467

NCT05264584

Known as isotonic saline solution isotonic saline solution infusion (fluid preloading) to achieve correction of hypovolemia before spinal anesthesia using cardiac ultrasoud guidance by measurment of VTI...” NCT07108881
1

NCT00702728

Known as MOVICOL “one sacket of Movicol powder (13 g macrogol 3350)” NCT06022302
1

NCT00796354

Known as NaCl “Treatment of the metabolic alkalosis with volume and sodium chloride (NaCl) replacement could reduce hypoventilation and hypercapnia, thereby improving symptoms, sleep patterns...” NCT00163852
10

“dispersible NaCl powder, 8 mg per session per hour (one administration in each nostril and two oral inhalations)” NCT05196581

“supplemental 3ml 0.9% Sodium chloride (NaCl) solution in a nasal nebuliser once a day for 3 months” NCT03011632

“0.9% Sodium Chloride (NaCl) saline will be used as nasal irrigation for two groups.” NCT04213508

“50 mL of 10% hypertonic sodium chloride (NaCl)” NCT07596329

“Sodium Chloride (NaCl) 0.9 %” NCT07188766

“0.9 % sodium chloride (NaCl)” PMID 27480410 Aug 2016

“Normal Saline (0.9% NaCl)” NCT07486245

NCT06158555

NCT00540904

NCT01812525

Known as NaCl 0.9% ClinicalTrials.gov intervention name — accepted as the source's own label NCT03630224
Known as Natrum muriaticum ClinicalTrials.gov intervention name — accepted as the source's own label NCT02402049
Known as Normal (0.9%) saline ClinicalTrials.gov intervention name — accepted as the source's own label NCT01547130
Known as normal saline “Drug: 0.9% Isotonic Saline (IS) 4 mL of IS will be administered via inhalation twice daily for 48 weeks The delivery system is the same as that for the test product. Other...” NCT02950883
83

“The purpose of this study is to compare a large volume ACE flush using a salt water solution called normal saline with a small volume ACE flush using liquid glycerin.” NCT02435069

“Patient will receive normal saline or Ringer lactate or other balance salt solution during fluid resuscitation for shock reversal.” NCT02782819

Normal saline will be give to subjects in the standard arm as the current standard of care for an initial resuscitation fluid” NCT01838863

“Basal infusion of crystalloid (normal saline,Ringer's lactate,Ringer's solution)variable from 4 to 12 ml/kg/hour.” NCT01882920

“The placebo group is resuscitated with normal saline, the experimental group is resuscitated with balanced fluid.” NCT03188614

“0.9% Normal Saline (0.9% Sodium Chloride) injection intravenously as needed.” NCT02668952

“stoma enemas (20mlkgdo of normal saline 3 times a day) will be prescribed” NCT02530346

“0.9% normal saline infusion and boluses of mannitol” NCT01111682

normal saline, dextrose, lactated Ringer's” NCT02632630

“Drug: Normal salineNCT05209841

NCT01016249

NCT01128413

NCT01871857

NCT00964015

NCT03880903

NCT06339203

NCT02383992

NCT00583466

NCT03136458

NCT03340805

NCT07497542

NCT06953674

NCT05194761

NCT00514150

NCT05980494

NCT00474162

NCT01285713

NCT06370975

NCT03563378

NCT07260240

NCT06030609

NCT05634213

NCT01692769

NCT02476448

NCT02227329

NCT02564016

NCT05355974

NCT07647575

NCT03533777

NCT03166228

NCT01823848

NCT01271114

NCT02590081

NCT03063476

NCT01939145

NCT05921695

NCT00878631

NCT05121389

NCT02203123

NCT04102371

NCT00819416

NCT02221024

NCT06374823

NCT00273728

NCT03277677

NCT07138625

NCT02305199

NCT03115060

NCT07035509

NCT03215862

NCT03054922

NCT02520804

NCT07486245

NCT05772234

NCT02854683

NCT00308152

NCT06343493

NCT01073787

NCT04621981

NCT06363877

NCT03066440

NCT02641561

NCT05707936

NCT06139029

NCT00696540

NCT07202559

NCT06950229

NCT02413125

NCT01585740

NCT02989571

NCT05029596

NCT02336620

NCT05781243

Known as normal saline solution “The aim of this study was to show that 6% hydroxyethyl starch (HES) 130/0.4 achieves a better resuscitation of the microcirculation than normal saline solution (SS), during...” PMID 20813485 Sep 2010
3

“Ringer lactate solution (RLS) and normal saline solution (NSS) with dextrose water (D5W)” NCT06030609

normal saline solution (0.9% sodium chloride)” NCT02707549

“Drug: Normal Saline SolutionNCT02785133

Known as Normal saline. Isotonic saline. Sodium Chloride 0.9% . Normal saline. Isotonic saline. Sodium Chloride 0.9% .NCT00639912
Known as NSS “Ringer lactate solution (RLS) and normal saline solution (NSS) with dextrose water (D5W)” NCT06030609
Known as PARI Hyper-Sal PARI Hyper-Sal™ Sodium Chloride Solution - 7%” NCT02276898
Known as physiological saline physiological saline 20 mL (distention)” PMID 18415773 Mar 2008